Table 3.

Therapy prescribed in COPD patients before bronchoscopy and at discharge after bronchoscopy

	No decline (n. patients)	Slow decline (n. patients)	Rapid decline (n. patients)
Current therapy before bronchoscopy
ICS (BDP pMDI)	6	3	3
LAMA end/or LABA or SAMA and/or SABA	15	13	9
Theophylline	3	5	3
Any medication	5	1	5
Therapy at discharge after bronchoscopy
ICS (BDP pMDI)	11	5	9
LAMA end/or LABA or SAMA and/or SABA	16	13	13
Theophylline	3	5	4
Any medication	2	1	2

ICS inhaled corticosteroids, BDP beclomethasone dipropionate equivalent dose (μg/day), pMDI pressurized metered-dose inhaler, LAMA long-acting muscarinic antagonist, LABA long-acting beta2 agonist, SAMA short-acting muscarinic antagonist, SABA short-acting beta2 agonist. ICS use was excluded for a washout period of 1 month before bronchoscopy in all patients